Title for Episode VIII of world’s famous saga ‘Star Wars’ revealedSociety & Culture January 23, 21:19
Russia’s chief negotiator: Astana format gives hope for new level in negotiating processRussian Politics & Diplomacy January 23, 20:52
Astana talks focusing on mechanism of Syria ceasefire observance — oppositionWorld January 23, 20:23
Russia and Turkey hit Islamic State targets near al-Bab in Aleppo provinceWorld January 23, 20:06
Russia’s 4th Yasen-class submarine completes hydraulic testsMilitary & Defense January 23, 18:56
Arctic airport in search for investorsBusiness & Economy January 23, 18:50
Rosneft begins Arctic shelf’s seismological exploration from 2017Business & Economy January 23, 18:38
Tesla takes the lead in sales of electric cars in Russia in 2016Business & Economy January 23, 18:18
Politician says European-style reforms to degrade Ukraine’s economyWorld January 23, 18:16
DALIAN, China, Sept. 23, 2016 /PRNewswire/. On 21st Sept., the 2016 "Healthy China" Forum, hosted by the committee of Global Innovation Forum and sponsored by ZHEN-AO, Shuangdi, Inc. and Gene Tech Biotechnology Co. Ltd., was held in Dalian.
Experts at home and abroad attending the forum and exchanged their ideas and views on the future development of biotechnological innovation and advanced achievements based on current accomplishment of technological innovation of biotechnology and nucleotide. Rolf M. Zinkernagel, the Nobel laureate of Physiology or Medicine, Professor of University of Zurich, also attended the forum and introduced the cutting-edge researches on the safety and nutritional function of nucleotide as well as its future application in immunity and health field.
"Healthy China" is becoming a national strategy and provides a great opportunity for Precision Medicine industry. While enterprises, as a saying goes, "to forge iron, one must be strong", should never stop innovating so as to win the market, according to Chen Yuqi, the vice chairman of China Nutrition and Health Food Association, vice president of China Health Care Association and Chairman & CEO of ZHEN-AO.
ZHEN-AO, based in ZHEN-AO Bio Valley and located in Dalian Advanced Equipment Manufacturing Zone with an area of 38,000 square meters and a total investment over 2.2 billion yuan, is the first enterprise that introduced nucleotide to Chinese families. Bio-manufacturing, bio-pharmaceuticals, biological products, biological agriculture and biological environmental protection constitute the main pillar industries of ZHEN-AO.
Image Attachments Links:
CONTACT: Ms. Liu, Tel: 86 10 63074558